These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2515162)

  • 1. Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin.
    Cutts JL; Bankhurst AD
    Int J Immunopharmacol; 1989; 11(8):863-9. PubMed ID: 2515162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
    Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K
    Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lovastatin on natural killer cell function and other immunological parameters in man.
    McPherson R; Tsoukas C; Baines MG; Vost A; Melino MR; Zupkis RV; Pross HF
    J Clin Immunol; 1993 Nov; 13(6):439-44. PubMed ID: 8288727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
    Weber C; Erl W; Weber KS; Weber PC
    J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.
    Cutts JL; Bankhurst AD
    J Cell Physiol; 1990 Nov; 145(2):244-52. PubMed ID: 2246324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation.
    Chakrabarti R; Engleman EG
    J Biol Chem; 1991 Jul; 266(19):12216-22. PubMed ID: 1712015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
    Peffley DM; Gayen AK
    J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
    Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
    Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.
    Carlberg M; Dricu A; Blegen H; Wang M; Hjertman M; Zickert P; Höög A; Larsson O
    J Biol Chem; 1996 Jul; 271(29):17453-62. PubMed ID: 8663239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
    Dimitroulakos J; Lorimer IA; Goss G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4426s-4431s. PubMed ID: 16857822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
    Wang W; Macaulay RJ
    Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
    Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.